High Tide Makes ROB Annual Ranking of Canada's Top Growing Companies for Fifth Consecutive Year
High Tide Inc. (NASDAQ: HITI) has secured the 182nd position among 400 companies in the 2025 Report on Business ranking of Canada's Top Growing Companies, achieving a three-year revenue growth rate of 188%. This marks the company's fifth consecutive year on the prestigious list, following their 2024 ranking of 87th with a 486% growth rate.
The cannabis retail enterprise has expanded significantly, with its subsidiary Canna Cabana operating 210 locations across Canada and commanding a 12% market share. The company recently completed a majority acquisition of Remexian Pharma GmbH, a German pharmaceutical company licensed to import medical cannabis from 19 countries, marking High Tide's strategic entry into Europe's largest cannabis market.
High Tide continues to receive recognition for its growth, including rankings on the TSX Venture Exchange's top 50 companies and the Financial Times' list of Americas' Fastest Growing Companies.
High Tide Inc. (NASDAQ: HITI) ha conquistato la 182ª posizione su 400 aziende nel 2025 Report on Business delle Top Growing Companies del Canada, con un tasso di crescita del fatturato triennale del 188%. Si tratta della quinta presenza consecutiva dell’azienda nella prestigiosa lista, dopo il 2024 in cui si era classificata all’87° posto con una crescita del 486%. L’azienda di vendita al dettaglio di cannabis si è espansa notevolmente: la controllata Canna Cabana opera su 210 sedi in tutto il Canada e detiene una quota di mercato del 12%. Recentemente la società ha completato l’acquisizione maggioritaria di Remexian Pharma GmbH, un’azienda farmaceutica tedesca autorizzata a importare cannabis medica da 19 paesi, segnando l’ingresso strategico di High Tide nel più grande mercato della cannabis in Europa. High Tide continua a ricevere riconoscimenti per la sua crescita, tra cui posizioni tra le prime 50 aziende della TSX Venture Exchange e l’inclusione nella lista di Financial Times delle Americas’ Fastest Growing Companies.
High Tide Inc. (NASDAQ: HITI) ha asegurado la 182ª posición entre 400 empresas en el Informe 2025 sobre las Empresas de Mayor Crecimiento de Canadá, logrando una tasa de crecimiento de ingresos a tres años del 188%. Esto marca la quinta participación consecutiva de la empresa en la prestigiosa lista, tras su ranking de 2024 en la 87ª posición con un crecimiento del 486%. La empresa minorista de cannabis ha crecido notablemente, con su subsidiaria Canna Cabana operando 210 locales en Canadá y con una cuota de mercado del 12%. Recientemente la compañía completó la adquisición mayoritaria de Remexian Pharma GmbH, una empresa farmacéutica alemana autorizada para importar cannabis médico de 19 países, marcando la entrada estratégica de High Tide en el mercado de cannabis más grande de Europa. High Tide continúa recibiendo reconocimientos por su crecimiento, incluyendo clasificaciones en las 50 mejores empresas de la TSX Venture Exchange y en la lista de Financial Times de las Americas’ Fastest Growing Companies.
High Tide Inc. (NASDAQ: HITI)가 2025년 캐나다 상위 성장 기업 순위에서 400개 중 182위를 차지했으며, 3년 매출 성장률 188%를 기록했습니다. 이는 이 회사가 명망 있는 목록에 5년 연속으로 이름을 올린 것이며, 2024년에는 성장률 486%로 87위를 차지했습니다. 캐나다 전역에서 210개의 매장을 운영하는 자회사 Canna Cabana가 cannabis 소매 기업으로 큰 확장을 이뤘고, 시장 점유율 12%를 차지하고 있습니다. 또한 최근 Remexian Pharma GmbH의 대다수 지분을 인수하여 독일의 의약용 대마를 19개국에서 수입할 수 있도록 허가받은 회사로, 유럽 최대의 대마 시장에 전략적으로 진입했습니다. High Tide는 TSX 벤처 주식시장 상위 50대 기업 및 Financial Times의 Americas’ Fastest Growing Companies 목록 등 성장 인정을 계속 받고 있습니다.
High Tide Inc. (NASDAQ: HITI) a assuré la 182e place sur 400 entreprises dans le classement 2025 du Report on Business des Canadian Top Growing Companies, affichant un taux de croissance sur trois ans du chiffre d’affaires de 188%. Il s’agit de la cinquième année consécutive de présence de l’entreprise sur cette liste prestigieuse, après un classement en 2024 à la 87e place avec une croissance de 486%. L’entreprise de commerce de détail de cannabis s’est largement développée : sa filiale Canna Cabana exploite 210 points de vente à travers le Canada et détient une part de marché de 12%. Récemment, la société a finalisé l’acquisition majoritaire de Remexian Pharma GmbH, une entreprise pharmaceutique allemande autorisée à importer du cannabis médical dans 19 pays, marquant l’entrée stratégique d’High Tide sur le plus grand marché européen du cannabis. High Tide continue à recevoir des distinctions pour sa croissance, notamment des classements parmi les 50 meilleures entreprises de la TSX Venture Exchange et la liste des Americas’ Fastest Growing Companies du Financial Times.
High Tide Inc. (NASDAQ: HITI) hat den 182. Platz von 400 Unternehmen im Report on BusinessRanking der kanadischen Top Growing Companies 2025 erreicht und eine dreijährige Umsatzwachstumsrate von 188% erzielt. Dies markiert das fünfte aufeinanderfolgende Jahr des Unternehmens auf der renommierten Liste, nachdem es 2024 den 87. Platz mit einem Wachstum von 486% belegte. Das Cannabis-Einzelhandelsunternehmen hat erheblich expandiert: Die Tochtergesellschaft Canna Cabana betreibt 210 Standorte in Kanada und hält einen Marktanteil von 12%. Das Unternehmen hat zudem kürzlich die Mehrheitsbeteiligung an Remexian Pharma GmbH abgeschlossen, einem deutschen Pharmaunternehmen, das berechtigt ist, medizinisches Cannabis aus 19 Ländern zu importieren, was High Tide einen strategischen Einstieg in Europas größten Cannabismarkt ermöglicht. High Tide erhält weiterhin Anerkennung für sein Wachstum, unter anderem durch Rankings der TSX Venture Exchange in den Top 50-Unternehmen und die Aufnahme in die Liste der Americas’ Fastest Growing Companies des Financial Times.
High Tide Inc. (NASDAQ: HITI) حققت المرتبة 182 من بين 400 شركة في تقرير الأعمال لعام 2025 لبوابة الشركات الكندية الأسرع نمواً، محققة معدل نمو إيرادات على مدى ثلاث سنوات بلغ 188%. وهذا يمثل السنة الخامسة على التوالي للشركة ضمن تلك القائمة المرموقة، عقب تصنيفها في عام 2024 في المرتبة 87 مع نمو قدره 486%. شركة التجزئة المتخصصة في القنب ازدادت توسعاً بشكل ملحوظ، حيث تشغّل شركة Canna Cabana التابعة لها 210 مواقع في جميع أنحاء كندا وتملك حصة سوقية قدرها 12%. كما أتمّت الشركة مؤخرًا الاستحواذ المسيطر على Remexian Pharma GmbH، وهي شركة أدوية ألمانية تدعم استيراد القنب الطبي من 19 دولة، مما يمثل دخول High Tide الاستراتيجي إلى أكبر سوق للقنب في أوروبا. وتواصل High Tide تلقي تقدير لنموها، بما في ذلك تصنيفات ضمن أفضل 50 شركة في TSX Venture Exchange وقائمة Financial Times لأسرع الشركات نمواً في الأمريكتين.
High Tide Inc. (NASDAQ: HITI) 在加拿大2025年“最佳成长公司”榜单中，在400家企业中排名第182位，Three-year Revenue Growth Rate达到188%。这是该公司连续第五年入选该颁奖名单，继2024年以486%的增长率排名第87位之后。该大麻零售企业显著扩张，其子公司Canna Cabana在加拿大开设了210家门店，市场份额为12%。公司最近完成对Remexian Pharma GmbH的多数股权收购，这是一家在德国注册、获许可从19个国家进口医用大麻的药品公司，标志着High Tide在欧洲最大的大麻市场实现战略进入。High Tide 继续因增长而获誉，包括在TSX Venture Exchange前50家公司中的排名，以及Finance Times的Americas’ Fastest Growing Companies名单。
- Achieved 188% three-year revenue growth rate
- Expanded retail presence to 210 Canna Cabana locations with 12% market share
- Successfully entered European market through Remexian Pharma acquisition
- Maintained consistent growth recognition for five consecutive years
- Diversified operations across retail, e-commerce, and medical cannabis distribution
- Declining growth rate from 486% in 2024 to 188% in 2025
- Lower ranking position from 87th in 2024 to 182nd in 2025
This follows the Company's 2024 ranking of 87th out of 417 companies, with a three-year growth rate of
"For the fifth consecutive year, High Tide has been recognized by Report on Business as one of
"While this recognition highlights the success of our Canadian operations to date, the recent closing of our majority acquisition of Remexian marks the beginning of an exciting new chapter for High Tide. By entering
"Our annual ranking of
ABOUT REPORT ON BUSINESS
Report on Business magazine is the trusted source for business leaders and ambitious Canadians making a difference. With a monthly readership of 2.7 million across print and digital, Report on Business is the premier magazine for leaders across industries, corporations, start-ups, and small businesses.
ABOUT HIGH TIDE
High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:
Retail: Canna Cabana™ is the largest cannabis retail chain in
Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.
High Tide consistently moves ahead of the currents, having been named one of
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: our ability of the Remexian acquisition to enhance our revenue profile, broaden our international footprint, and create new opportunities for long-term growth. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
CONTACT INFORMATION
Media Inquiries
Carter
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080
Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-makes-rob-annual-ranking-of-canadas-top-growing-companies-for-fifth-consecutive-year-302567823.html
SOURCE High Tide Inc.
FAQ
What is High Tide's (HITI) ranking in Canada's Top Growing Companies for 2025?
How many Canna Cabana retail locations does High Tide (HITI) currently operate?
What is the significance of High Tide's Remexian acquisition?
How has High Tide's (HITI) growth rate changed from 2024 to 2025?
What recent recognitions has High Tide (HITI) received?
